美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=NDA211566"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
70771-1770-3 70771-1770 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 25 mg/1 30 TABLET in 1 BOTTLE (70771-1770-3)
70771-1770-9 70771-1770 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 25 mg/1 90 TABLET in 1 BOTTLE (70771-1770-9)
70771-1771-3 70771-1771 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 50 mg/1 30 TABLET in 1 BOTTLE (70771-1771-3)
70771-1771-9 70771-1771 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 50 mg/1 90 TABLET in 1 BOTTLE (70771-1771-9)
70771-1772-3 70771-1772 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 100 mg/1 30 TABLET in 1 BOTTLE (70771-1772-3)
70771-1772-9 70771-1772 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 100 mg/1 90 TABLET in 1 BOTTLE (70771-1772-9)
70771-1790-3 70771-1790 HUMAN PRESCRIPTION DRUG Sitagliptin Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 25 mg/1 30 TABLET in 1 BOTTLE (70771-1790-3)
70771-1790-9 70771-1790 HUMAN PRESCRIPTION DRUG Sitagliptin Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 25 mg/1 90 TABLET in 1 BOTTLE (70771-1790-9)
70771-1791-3 70771-1791 HUMAN PRESCRIPTION DRUG Sitagliptin Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 50 mg/1 30 TABLET in 1 BOTTLE (70771-1791-3)
70771-1791-9 70771-1791 HUMAN PRESCRIPTION DRUG Sitagliptin Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 50 mg/1 90 TABLET in 1 BOTTLE (70771-1791-9)
70771-1792-3 70771-1792 HUMAN PRESCRIPTION DRUG Sitagliptin Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 100 mg/1 30 TABLET in 1 BOTTLE (70771-1792-3)
70771-1792-9 70771-1792 HUMAN PRESCRIPTION DRUG Sitagliptin Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Lifesciences Limited SITAGLIPTIN 100 mg/1 90 TABLET in 1 BOTTLE (70771-1792-9)
70710-1240-3 70710-1240 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Pharmaceuticals (USA) Inc. SITAGLIPTIN 25 mg/1 30 TABLET in 1 BOTTLE (70710-1240-3)
70710-1240-9 70710-1240 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Pharmaceuticals (USA) Inc. SITAGLIPTIN 25 mg/1 90 TABLET in 1 BOTTLE (70710-1240-9)
70710-1241-3 70710-1241 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Pharmaceuticals (USA) Inc. SITAGLIPTIN 50 mg/1 30 TABLET in 1 BOTTLE (70710-1241-3)
70710-1241-9 70710-1241 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Pharmaceuticals (USA) Inc. SITAGLIPTIN 50 mg/1 90 TABLET in 1 BOTTLE (70710-1241-9)
70710-1242-3 70710-1242 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Pharmaceuticals (USA) Inc. SITAGLIPTIN 100 mg/1 30 TABLET in 1 BOTTLE (70710-1242-3)
70710-1242-9 70710-1242 HUMAN PRESCRIPTION DRUG ZITUVIO Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Pharmaceuticals (USA) Inc. SITAGLIPTIN 100 mg/1 90 TABLET in 1 BOTTLE (70710-1242-9)
70710-1899-3 70710-1899 HUMAN PRESCRIPTION DRUG Sitagliptin Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Pharmaceuticals (USA) Inc. SITAGLIPTIN 25 mg/1 30 TABLET in 1 BOTTLE (70710-1899-3)
70710-1899-9 70710-1899 HUMAN PRESCRIPTION DRUG Sitagliptin Sitagliptin TABLET ORAL 20231130 N/A NDA NDA211566 Zydus Pharmaceuticals (USA) Inc. SITAGLIPTIN 25 mg/1 90 TABLET in 1 BOTTLE (70710-1899-9)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase